Insider · CIK 0001053369
Elite Pharmaceuticals Inc /nv/
Files at ELTP (ELITE PHARMACEUTICALS INC /NV/). First filing Aug 26, 2025, latest Aug 26, 2025.
Elite Pharmaceuticals Inc /nv/ files SEC Form 4 as officer at ELTP (ELITE PHARMACEUTICALS INC /NV/). Since Aug 26, 2025, Elite Pharmaceuticals Inc /nv/ has reported 0 open-market buys worth $0 and 1 open-market sell worth $262k, the latest filed on Aug 26, 2025.
A track record needs three past buys with six months of prices behind them; Elite Pharmaceuticals Inc /nv/ has 0, so none is measured yet.
The newest scored trade: sold $262k of ELTP on Aug 22, 2025, filed Aug 26, 2025, scored 18 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ELTP: ELITE PHARMACEUTICALS INC /NV/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | $262k 500,000 shares | -22% | +72% from low-29% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | ELTP ELITE PHARMACEUTICALS INC /NV/ | SOpen-market sale Common Stock | -500,000 | $0.52 | $262k | 1,800,000 | Aug 26, 2025 |
| Aug 25, 2025 | ELTP ELITE PHARMACEUTICALS INC /NV/ | MOption exercise Common Stock | +2,500,000 | $0.03 | $75k | 4,300,000 | Aug 26, 2025 |
| Aug 25, 2025 | ELTP ELITE PHARMACEUTICALS INC /NV/ | MOption exercise Stock Options (right to buy)derivative | -2,500,000 | $0.00 | $0 | 2,500,000 | Aug 26, 2025 |
Questions about Elite Pharmaceuticals Inc /nv/
Answered from the filings on this page, as of the latest one.
Is Elite Pharmaceuticals Inc /nv/ buying or selling?
Not in the last 12 months. Elite Pharmaceuticals Inc /nv/'s latest open-market trade on SEC Form 4 was sold $262k of ELTP on Aug 22, 2025.
How did Elite Pharmaceuticals Inc /nv/'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elite Pharmaceuticals Inc /nv/ has 0.
Where does Elite Pharmaceuticals Inc /nv/ file Form 4?
Elite Pharmaceuticals Inc /nv/ has filed Form 4 at ELTP (ELITE PHARMACEUTICALS INC /NV/) as EVP Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.